Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Satoko Ito, Karthik Chetlapalli, Daniel Wang, Kunal C Potnis, Rhys Richmond, Harlan Krumholz, Alfred I Lee, Adam Cuker, George Goshua

Blood blood.2024025176.

https://doi.org/10.1182/blood.2024025176

Published: 2024

Includes: Supplemental data

Journal Articles

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D. Bona, Adam Cuker, George Goshua

Blood (2024) 143 (22): 2332–2335.

https://doi.org/10.1182/blood.2024024209

Published: 2024

Includes: Supplemental data

Journal Articles

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 3698.

https://doi.org/10.1182/blood-2023-188018

Published: 2023

Journal Articles

A Phase III Clinical Trial Program Investigating the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1 and VAYHIT2) and Warm Autoimmune Hemolytic Anemia (VAYHIA)

Hanny Al-Samkari, Wilma Barcellini, Nichola Cooper, Waleed Ghanima, Marc Michel, Raymond SM Wong, Francesco Zaja, Fengkui Zhang, Patrick Urban, Alex Allepuz, Justyna Fronczek-Sokol, Jens Haenig, Pascal Edrich, Adam Cuker

Blood (2023) 142 (Supplement 1): 5456.

https://doi.org/10.1182/blood-2023-180647

Published: 2023

Journal Articles

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 368.

https://doi.org/10.1182/blood-2023-184927

Published: 2023

Journal Articles

Ianalumab, a Novel Anti-B-Cell Activating Factor (BAFF) Receptor (BAFF-R) Monoclonal Antibody (mAb) in Development for Immune Thrombocytopenia (ITP) and Warm Autoimmune Hemolytic Anemia (wAIHA), Has Demonstrated a Favorable Safety Profile in Sjögren's Syndrome (SjS), Systemic Lupus Erythematosus (SLE) and Chronic Lymphocytic Leukemia (CLL)

Adam Cuker, Hanny Al-Samkari, Wilma Barcellini, Nichola Cooper, Waleed Ghanima, Marc Michel, Raymond SM Wong, Francesco Zaja, Fengkui Zhang, Patrick Urban, Roberto Abi Rached, David J Kuter

Blood (2023) 142 (Supplement 1): 5427.

https://doi.org/10.1182/blood-2023-180055

Published: 2023

Journal Articles

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 2316.

https://doi.org/10.1182/blood-2023-187270

Published: 2023

Journal Articles

Examining Postpartum Anticoagulation Practices: An International Survey of Healthcare Providers

Evangelia Vlachodimtropoulou Koumoutsea, A. Kinga Malinowski, Adam Cuker, Eric Kaplovitch, Nadine Shehata

Blood (2023) 142 (Supplement 1): 2643.

https://doi.org/10.1182/blood-2023-177611

Published: 2023

Journal Articles

Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review

Blood (2023) 142 (Supplement 1): 7239.

https://doi.org/10.1182/blood-2023-179448

Published: 2023

Journal Articles

TPO-RAs and ITP remission: cause or coincidence?

Kristen M. Sanfilippo, Adam Cuker

Blood (2023) 141 (23): 2790–2791.

https://doi.org/10.1182/blood.2023020243

Published: 2023

Journal Articles

Documentation of Menstrual Concerns in Patients with Inherited Bleeding Disorders

Ximena Tienhoven, Allyson M Pishko, Elaine Chiang, Adam Cuker, Ariela L. Marshall

Blood (2022) 140 (Supplement 1): 13134–13135.

https://doi.org/10.1182/blood-2022-159795

Published: 2022

Journal Articles

Fatigue and Cognition During Remission in Adults with Immune Thrombotic Thrombocytopenic Purpura

Shannon M Reeves, Amanda J Llaneza, Sara K. Vesely, Janna Journeycake, Mohamad O. Khawandanah, Marshall Mazepa, Frank Akwaa, Adam Cuker, Shruti Chaturvedi, Neil Zakai, Ming Yeong Lim, Radhika Gangaraju, San Keller, Spero Cataland, Deirdra R Terrell

Blood (2022) 140 (Supplement 1): 1228–1229.

https://doi.org/10.1182/blood-2022-170139

Published: 2022

Journal Articles

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig Kessler, Caroline Kruse, Andrew D. Leavitt, Alfred I. Lee, Howard A. Liebman, Adrian C. Newland, Ashley E. Ray, Michael D. Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B. Bussel

Blood (2022) 139 (10): 1564–1574.

https://doi.org/10.1182/blood.2021013411

Published: 2022

Includes: Supplemental data

Journal Articles

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Hanny Al-Samkari, Debbie Jiang, Terry B. Gernsheimer, Howard A. Liebman, Susie Lee, Chelsea Bernheisel, Scott Kolodny, Matthew Wojdyla, Michael Vredenburg, Brian Jamieson, Adam Cuker

Blood (2021) 138 (Supplement 1): 1015.

https://doi.org/10.1182/blood-2021-151321

Published: 2021

Journal Articles

Preferences for Accessing Patient Reported Outcomes and Health Information Among Thrombotic Thrombocytopenic Purpura Survivors

Deirdra Terrell, Rachel Ann Kelley, Amanda J Llaneza, Sara K. Vesely, Janna Journeycake, Mohamad O. Khawandanah, Marshall Mazepa, Frank Akwaa, Adam Cuker, Shruti Chaturvedi, Neil A. Zakai, Ming Yeong Lim, Radhika Gangaraju, Spero Cataland

Blood (2021) 138 (Supplement 1): 3039.

https://doi.org/10.1182/blood-2021-153407

Published: 2021

Journal Articles

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia

Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer MacWhirter - DiRaimo, Terry B. Gernsheimer, Alexandra Kruse, Craig M. Kessler, Caroline Kruse, Andrew D Leavitt, Alfred Ian Lee, Howard A. Liebman, Adrian C. Newland, Ashley E. Ray, Michael D Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B Bussel

Blood (2021) 138 (Supplement 1): 586.

https://doi.org/10.1182/blood-2021-152918

Published: 2021

Journal Articles

Creating Clinical Meaning for the Promis Cognitive Function Abilities Instrument: Improving Remission Outcomes for Adults with Thrombotic Thrombocytopenic Purpura

Deirdra Terrell, Kalyn Neighbors, Amanda J Llaneza, Rachel Ann Kelley, Sara K. Vesely, Janna Journeycake, Mohamad O. Khawandanah, Marshall Mazepa, Frank Akwaa, Adam Cuker, Shruti Chaturvedi, Neil A. Zakai, Ming Yeong Lim, Radhika Gangaraju, San Keller, Spero Cataland

Blood (2021) 138 (Supplement 1): 834.

https://doi.org/10.1182/blood-2021-153720

Published: 2021

Journal Articles

Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune Thrombocytopenia

George Goshua, Pranay Sinha, Lauren Pischel, Alfred Ian Lee, Adam Cuker

Blood (2021) 138 (Supplement 1): 751.

https://doi.org/10.1182/blood-2021-144819

Published: 2021

Journal Articles

Redefining outcomes in immune TTP: an international working group consensus report

Adam Cuker, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, James N. George, Paul N. Knoebl, Johanna A. Kremer Hovinga, Bernhard Lӓmmle, Masanori Matsumoto, Katerina Pavenski, Flora Peyvandi, Kazuya Sakai, Ravi Sarode, Mari R. Thomas, Yoshiaki Tomiyama, Agnès Veyradier, John-Paul Westwood, Marie Scully

Blood (2021) 137 (14): 1855–1861.

https://doi.org/10.1182/blood.2020009150

Published: 2021

Includes: Supplemental data

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

NARROW

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

A Phase III Clinical Trial Program Investigating the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1 and VAYHIT2) and Warm Autoimmune Hemolytic Anemia (VAYHIA)

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Examining Postpartum Anticoagulation Practices: An International Survey of Healthcare Providers

Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review

TPO-RAs and ITP remission: cause or coincidence?

Documentation of Menstrual Concerns in Patients with Inherited Bleeding Disorders

Fatigue and Cognition During Remission in Adults with Immune Thrombotic Thrombocytopenic Purpura

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Preferences for Accessing Patient Reported Outcomes and Health Information Among Thrombotic Thrombocytopenic Purpura Survivors

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia

Creating Clinical Meaning for the Promis Cognitive Function Abilities Instrument: Improving Remission Outcomes for Adults with Thrombotic Thrombocytopenic Purpura

Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune Thrombocytopenia

Redefining outcomes in immune TTP: an international working group consensus report

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only